Supriya Lifescience Limited (SUPRIYA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.051x

Based on the latest financial reports, Supriya Lifescience Limited (SUPRIYA) has a cash flow conversion efficiency ratio of 0.051x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs555.65 Million ≈ $6.01 Million USD) by net assets (Rs10.82 Billion ≈ $116.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Supriya Lifescience Limited fund operations to measure how many days the company can operate on defensive assets alone.

Supriya Lifescience Limited - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Supriya Lifescience Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Supriya Lifescience Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Supriya Lifescience Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shenzhen Comix Group Co Ltd SHE:002301	0.017x
BGT Group Co. Ltd. SHE:300774	N/A
Argo Properties NV TA:ARGO	0.019x
Seneca Foods Corp A NASDAQ:SENEA	0.044x
Shenzhen Chuangyitong Technology Co.Ltd. SHE:300991	-0.017x
Sagicor Financial Company TO:SFC	0.295x
Metro Healthcare Indonesia JK:CARE	0.005x
Winnebago Industries Inc NYSE:WGO	-0.020x

Annual Cash Flow Conversion Efficiency for Supriya Lifescience Limited (2018–2025)

The table below shows the annual cash flow conversion efficiency of Supriya Lifescience Limited from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see SUPRIYA stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs9.97 Billion ≈ $107.80 Million	Rs1.73 Billion ≈ $18.66 Million	0.173x	+24.58%
2024-03-31	Rs8.15 Billion ≈ $88.18 Million	Rs1.13 Billion ≈ $12.25 Million	0.139x	+46.86%
2023-03-31	Rs6.99 Billion ≈ $75.64 Million	Rs661.87 Million ≈ $7.16 Million	0.095x	+19.38%
2022-03-31	Rs6.16 Billion ≈ $66.58 Million	Rs488.01 Million ≈ $5.28 Million	0.079x	-73.33%
2021-03-31	Rs2.69 Billion ≈ $29.08 Million	Rs799.30 Million ≈ $8.64 Million	0.297x	-61.80%
2020-03-31	Rs1.49 Billion ≈ $16.13 Million	Rs1.16 Billion ≈ $12.55 Million	0.778x	+49.91%
2019-03-31	Rs937.91 Million ≈ $10.14 Million	Rs486.72 Million ≈ $5.26 Million	0.519x	+62.52%
2018-03-31	Rs546.57 Million ≈ $5.91 Million	Rs174.52 Million ≈ $1.89 Million	0.319x	--

About Supriya Lifescience Limited

NSE:SUPRIYA India Biotechnology

Market Cap

$811.42 Million

Rs75.03 Billion INR

Market Cap Rank

#10001 Global

#493 in India

Share Price

Rs932.25

Change (1 day)

+1.96%

52-Week Range

Rs553.35 - Rs1052.50

All Time High

Rs1052.50